6-(Cyclopropanecarboxamido)-4-((2-methoxy-3-(1-methyl-1H-1,2,4-triazol-3-yl)phenyl)amino)pyridazine-3-carboxylic acid

ديوكرافاسيتينيب

active pharmaceutical ingredient

3-Pyridazinecarboxylic acid, 6-chloro-4-[[2-methoxy-3-(1-methyl-1H-1,2,4-triazol-3-yl)phenyl]amino]-

Pharmaceutical intermediate for deucravacitinib synthesis

Lithium 4,6-Dichloropyridazine-3-carboxylate

Pharmaceutical intermediate for deucravacitinib

Methyl 4,6-dichloropyridazine-3-carboxylate

Pharmaceutical intermediate for deucravacitinib

(2-Amino-5-nitrophenyl)(2-chlorophenyl)methanone Phthalimido

Pharmaceutical impurity reference standard

(2-(1-isopropyl-1H-pyrazol-5-yl)pyridin-3-yl)methanol hydrochloride

pharmaceutical intermediate

4-Amino-3-fluoropyridine

Pharmaceutical intermediate for BACE1 inhibitors

Py-MAA-Val-Cit-PAB-MMAE

antibody-drug conjugate linker payload